Literature DB >> 28921469

Microbial Factors in Inflammatory Diseases and Cancers.

Hong Sheng Ong1, Howard Chi Ho Yim2.   

Abstract

The intestinal microbes form a symbiotic relationship with their human host to harvest energy for themselves and their host and to shape the immune system of their host. However, alteration of this relationship, which is named as a dysbiosis, has been associated with the development of different inflammatory diseases and cancers. It is found that metabolites, cellular components, and virulence factors derived from the gut microbiota interact with the host locally or systemically to modulate the dysbiosis and the development of these diseases. In this book chapter, we discuss the role of these microbial factors in regulating the host signaling pathways, the composition and load of the gut microbiota, the co-metabolism of the host and the microbiota, the host immune system, and physiology. In particular, we highlight how each microbial factor can contribute in the manifestation of many diseases such as cancers, Inflammatory Bowel Diseases, obesity, type-2 diabetes, non-alcoholic fatty liver diseases, nonalcoholic steatohepatitis, and cardiovascular diseases.

Entities:  

Keywords:  Atherosclerosis; Cancers; Dysbiosis; GPCR; Inflammasome; Inflammation; Inflammatory Bowel Diseases (IBD); Inflammatory diseases; Microbial metabolites; Microbiota; NLR; Non-alcoholic fatty liver diseases (NAFLD); Non-alcoholic steatohepatitis (NASH); Obesity; TLR; Type 2 diabetes

Mesh:

Substances:

Year:  2017        PMID: 28921469     DOI: 10.1007/978-981-10-5987-2_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

Review 1.  From obesity through gut microbiota to cardiovascular diseases: a dangerous journey.

Authors:  Paolo Marzullo; Laura Di Renzo; Gabriella Pugliese; Martina De Siena; Luigi Barrea; Giovanna Muscogiuri; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2020-07-20

Review 2.  The role of the gut microbiota in health and cardiovascular diseases.

Authors:  Lu Wang; Shiqi Wang; Qing Zhang; Chengqi He; Chenying Fu; Quan Wei
Journal:  Mol Biomed       Date:  2022-10-11

Review 3.  Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy.

Authors:  Runqi Zhu; Tianqun Lang; Wenlu Yan; Xiao Zhu; Xin Huang; Qi Yin; Yaping Li
Journal:  Adv Sci (Weinh)       Date:  2021-03-09       Impact factor: 16.806

Review 4.  Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents.

Authors:  Carmen Garrido-Navas; Diego de Miguel-Perez; Jose Exposito-Hernandez; Clara Bayarri; Victor Amezcua; Alba Ortigosa; Javier Valdivia; Rosa Guerrero; Jose Luis Garcia Puche; Jose Antonio Lorente; Maria José Serrano
Journal:  Cells       Date:  2019-11-03       Impact factor: 6.600

Review 5.  Role of metabolites derived from gut microbiota in inflammatory bowel disease.

Authors:  Lie Zheng; Xin-Li Wen; Sheng-Lei Duan
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

6.  Host-microbiota interaction-mediated resistance to inflammatory bowel disease in pigs.

Authors:  Xuan Zhao; Lin Jiang; Xiuyu Fang; Zhiqiang Guo; Xiaoxu Wang; Baoming Shi; Qingwei Meng
Journal:  Microbiome       Date:  2022-07-30       Impact factor: 16.837

Review 7.  The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It.

Authors:  Heather Armstrong; Michael Bording-Jorgensen; Stephanie Dijk; Eytan Wine
Journal:  Cancers (Basel)       Date:  2018-03-20       Impact factor: 6.639

Review 8.  The influence of diet on anti-cancer immune responsiveness.

Authors:  Laura Soldati; Laura Di Renzo; Emilio Jirillo; Paolo A Ascierto; Francesco M Marincola; Antonino De Lorenzo
Journal:  J Transl Med       Date:  2018-03-20       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.